Syn-One Test for Essential Tremor Patients

Analysis of Cutaneous Phosphorylated Alpha-Synuclein to Identify Patients at Risk of Progressing From Essential Tremor to Parkinson's Disease

Recruiting Observational Study
Essential Tremor, Movement Disorders Essential Tremor Essential Tremor-plus
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
50 – 85
Sex
Any
Study type
Observational
Participants needed
300 (estimated)
Sponsor
CND Life Sciences · Other
Who this trial is looking for

This trial is looking for adults aged 50 to 85 with essential tremor. Participants will undergo a simple skin biopsy to help identify those at risk of developing Parkinson's disease.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am between 50 and 85 years old.
  • I have been diagnosed with essential tremor.
  • I have had my tremor for at least 3 years.
  • I am willing to participate in all study procedures.
  • I can provide written informed consent.

You may not be able to join if

  • I am under 50 or over 85 years old.
  • I have severe peripheral vascular disease.
  • I have active coronary or cerebrovascular disease.
  • I am on anticoagulant or dual anti-platelet therapy.
  • I have a history of alcoholism.
  • I have an allergic reaction to local anesthesia.
  • I have a history of impaired wound healing or keloid formation.
  • I have another neurodegenerative disorder.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial
Background and Rationale Essential tremor (ET) affects over 6 million Americans and approximately 5% of adults over age 60. Patients with ET have a 10-20 times higher risk of developing Parkinson's disease (PD) compared to age-matched populations, with approximately 1% converting to PD annually. Post-mortem studies reveal Lewy body pathology in some ET patients, suggesting a subset may have prodro…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Age 50-85 years old * Diagnosis of ET as defined by the 2018 MDS Task force paper "1) isolated tremor syndrome of bilateral upper limb action tremor 2) at least 3 years' duration 3) with or without tremor in other locations (e.g., head, voice, or lower limbs) 4) absence of oth…
Contacts

Jeannie Director of Clinical Research

480-434-6446

ClinicalResearch@cndlifesciences.com

CONTACT